MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon.
暂无分享,去创建一个
[1] V. ter meulen,et al. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line , 1993, Journal of virology.
[2] P. Staeheli,et al. Mx proteins: GTPases with antiviral activity. , 1993, Trends in cell biology.
[3] K. Melén,et al. Control of IFN-inducible MxA gene expression in human cells. , 1993, Journal of immunology.
[4] M. Horisberger. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins , 1992, Journal of virology.
[5] A. Schmitz,et al. A whole blood immunoassay for the interferon-inducible human Mx protein. , 1992, Journal of Interferon Research.
[6] S. Baron. Interferon : principles and medical applications , 1992 .
[7] O. Haller,et al. Mx genes show weaker primary response to virus than other interferon-regulated genes. , 1992, Virology.
[8] O. Haller,et al. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines , 1991, Journal of virology.
[9] D. Näf,et al. A Novel, Quantitative Bioassay for Type I Interferon Using a Recombinant Indicator Cell Line , 1990, Bio/Technology.
[10] H. Hochkeppel,et al. Correlation of the antiproliferative effect and the Mx-homologous protein induction by IFN in patients with malignant melanoma. , 1990, The Journal of investigative dermatology.
[11] H. Hochkeppel,et al. The human intracellular Mx‐homologous protein is specifically induced by type I interferons , 1990, European journal of immunology.
[12] M. Lindstrom,et al. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages. , 1990, Journal of interferon research.
[13] O. Haller,et al. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.
[14] H. Hochkeppel,et al. Emergence and decay of the human Mx homolog in cancer patients during and after interferon-alpha therapy. , 1990, Journal of biological response modifiers.
[15] H. Hochkeppel,et al. The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. , 1990, AIDS.
[16] O. Haller,et al. Akkumulation von Mx-mRNA als Maß für die biologische Wirksamkeit von Interferon , 1990 .
[17] P. Staeheli. Interferon-induced proteins and the antiviral state. , 1990, Advances in virus research.
[18] H. Hochkeppel,et al. MX HOMOLOGOUS PROTEIN IN MONONUCLEAR CELLS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS , 1989, Arthritis and rheumatism.
[19] H. Zeller,et al. Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses , 1989, Journal of Virology.
[20] E. Borden,et al. Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta Ser. , 1989, Journal of interferon research.
[21] E. Borden,et al. Accumulation of guanylate binding proteins in patients treated with interferons. , 1988, Journal of interferon research.
[22] J. Gugenheim,et al. Interferon messenger RNA is produced constitutively in the organs of normal individuals. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[24] J. Sutcliffe,et al. Transcriptional activation of the mouse Mx gene by type I interferon , 1986, Molecular and cellular biology.
[25] M. Aguet,et al. Absence of detectable serum interferon in acute and chronic viral hepatitis , 1986, Hepatology.
[26] J. Vannier,et al. Enhanced level of double-stranded RNA-dependent protein kinase in peripheral blood mononuclear cells of patients with viral infections. , 1986, Journal of interferon research.
[27] M. Pignatelli,et al. Viruses and immune reactions in the liver. , 1985, Scandinavian journal of gastroenterology. Supplement.
[28] V. Gerein,et al. (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis. , 1984, Journal of interferon research.
[29] D. Fuchs,et al. Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. , 1983, Transplantation.
[30] J. Goedert,et al. Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. , 1983, The New England journal of medicine.
[31] A. Hovanessian,et al. Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases. , 1983, Annales d'immunologie.
[32] R. Friedman,et al. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. , 1982, Science.
[33] D. Wallach,et al. ASSAY OF AN INTERFERON-INDUCED ENZYME IN WHITE BLOOD CELLS AS A DIAGNOSTIC AID IN VIRAL DISEASES , 1981, The Lancet.
[34] J. Parry,et al. INTERFERON ASSAY AS A DIAGNOSTIC TEST , 1981, The Lancet.
[35] S. Pestka,et al. Convenient assay for interferons , 1981, Journal of virology.
[36] D. Wallach,et al. Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells. , 1981, Journal of interferon research.
[37] P. Evrin,et al. Serum 2 -microglobulin in various disorders. , 1973, Clinica chimica acta; international journal of clinical chemistry.
[38] R. Purcell,et al. Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[39] Wheelock Ef,et al. CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965 .
[40] T. Merigan,et al. CIRCULATING INTERFERON AFTER MEASLES VACCINATION. , 1965, The New England journal of medicine.
[41] W. Sibley,et al. CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. , 1965, The New England journal of medicine.